Archives
Instant Clot-Forming Antibacterial Dressings
2026-09-28
A 2024 study developed a bilayer wound dressing combining tranexamic acid, an NO donor, and propolis to address hemorrhage and bacterial contamination simultaneously. The formulation produced a dense fibrin network and strong activity against Staphylococcus aureus and multidrug-resistant Acinetobacter baumannii, while also highlighting important limits in translating material-level findings to clinical trauma care.
NF 449: Interpreting P2X1 Selectivity in Platelets
2026-09-28
NF 449 is a potent purinergic receptor antagonist used to investigate ATP-driven P2X1 signaling in platelets. This article explains why potency depends on assay context, how to interpret dose-dependent selectivity, and what the evidence can—and cannot—support in antithrombotic agent research.
Sphingosine-1-phosphate Workflows for Apoptosis Research
2026-09-27
Use Sphingosine-1-phosphate (S1P) to probe receptor-linked survival and apoptosis with workflows that connect early signaling to later cell-death readouts. A recent intracerebral hemorrhage study highlights an S1PR3-associated TNF-α/caspase-3 pathway, while practical controls help distinguish receptor effects from lipid handling and vehicle artifacts.
A More Efficient GRO-seq Protocol for Bread Wheat
2026-09-26
Chen and colleagues describe a bread wheat GRO-seq workflow that adds rRNA depletion between nuclear RNA isolation and nascent RNA immunoprecipitation. In their enhancer-transcription application, the modification increased the proportion of valid sequencing data by 20-fold, offering a practical way to reduce sequencing waste in a large, complex genome.
Berberrubine Chloride: Mechanisms and Research Use
2026-09-25
Berberrubine chloride is a research alkaloid with reported activity across cancer, urate regulation, and inflammation models. This evidence-focused guide separates product-dossier benchmarks from the narrower peer-reviewed antifungal evidence and summarizes practical use limits.
Puromycin Aminonucleoside: Renal Injury Workflows
2026-09-25
Build a controlled podocyte injury model with a compound used to study proteinuria and glomerular damage—not as an antibiotic selection reagent. This guide connects practical cell and animal workflows with concentration, pH, solubility, and interpretation safeguards.
PreScission Protease (PSP): Practical Cleavage Guide
2026-09-24
PreScission Protease (PSP) is an HRV 3C protease fusion enzyme for cleaving compatible affinity-tagged recombinant proteins at a defined recognition sequence. Use it when the construct contains an accessible cleavage site; it is not a general-purpose protease for proteins lacking that sequence.
Tunable 3D Gold Nanocluster Arrays for SERS
2026-09-24
The study combines polymer pen lithography (PPL) with electrostatic gold nanoparticle assembly to create ordered, tunable three-dimensional SERS substrates. The reported arrays reached an enhancement factor of 1.67 × 10⁷ and a relative standard deviation below 4.73%, highlighting a patternable route to sensitive, reproducible Raman measurements.
Heat-Not-Burn Product: Genotoxicity and Cytotoxicity
2026-09-23
This study compared a heat-not-burn product with conventional cigarettes using rat exposures and a multi-assay in vitro toxicology panel. The results indicate lower cytotoxicity and genotoxicity for the tested heat-not-burn product in several endpoints, while leaving important questions about exposure, product variability, and human health risk unresolved.
3D Gold Nanocluster Arrays for Reproducible SERS
2026-09-23
The reference study presents a polymer pen lithography strategy for constructing ordered three-dimensional gold nanoparticle cluster arrays on patterned polyethylenimine structures. By tuning pattern geometry and exploiting electrostatic nanoparticle assembly, the authors achieved strong SERS enhancement together with reported reproducibility below 4.73% RSD.
Berberrubine Chloride: Mechanism-to-Assay Guide
2026-09-22
Berberrubine chloride is a multi-target research compound whose effects span IMPDH2, TrxR, GSTM2, inflammatory signaling, and urate transport. This guide presents a mechanism-to-assay framework that separates established findings from practical validation strategies.
NF 449: Precision P2X1 Platelet Workflows
2026-09-22
NF 449 is a high-potency purinergic receptor antagonist for separating ATP-driven P2X1 signaling from broader platelet purinergic responses. This guide translates receptor pharmacology into platelet activation studies, collagen assays, and mechanism-aware antithrombotic agent research.
Vasopressin Analogues: Hormones to Multitasking Peptides
2026-09-21
Glavaš and colleagues present an integrative review of vasopressin biology, receptor pharmacology, and the structural evolution of peptide and non-peptide analogues. The study clarifies how changes in stability, receptor preference, and duration of action support applications ranging from treatment of diabetes insipidus and vasoconstriction research to emerging antiviral investigations.
CDK4–4E-BP1 Control During Mitosis–G1
2026-09-21
The reference study identifies CDK4 as a cell-cycle-linked kinase that phosphorylates 4E-BP1 and promotes cap-dependent translation during the mitosis–G1 transition. Its time-resolved and chemoproteomic framework expands interpretation of CDK4 beyond Rb phosphorylation and provides a useful design for connecting kinase activity with translational control in cancer research.
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-09-20
Boyle et al. showed that CCR7 signaling functionally intersects with Notch1 to sustain stem-like properties in primary MMTV-PyMT mammary cancer cells. The study supports a pathway-level model in which CCR7 activation promotes Notch1 signaling, while Notch inhibition suppresses CCR7-dependent stemness, providing a rationale for testing dual-axis intervention.
612 records 7/41 page Previous Next First page 上5页 678910 下5页 Last page